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The heterogeneity of Epstein-Barr virus (EBV) obtained from P3HR-1 cells has permitted derivation of a
distinct subclone of P3HR-1 (L. Heston, M. Rabson, N. Brown, and G. Miller, Nature (London) 295:160-163,
1982). We have analyzed the biologic properties and genomic structure of this subclonal virus (clone 13)
compared with those of parental P3HR-1 and B95-8 viruses. Synthesis of EBV proteins in Raji cells
superinfected with virus derived from P3HR-1, clone 13, and B95-8 was analyzed both by fluorography of
radiolabeled proteins and by immunoblotting. Highly concentrated preparations of clone 13 and B95-8 virus
induced most of the spectrum of EBV proteins in Raji cells with the exception of the 145,000-, 140,000-, and
110,000-molecular-weight proteins, which were either undetectable or reduced. Moreover, both clone 13 and
B95-8 viruses also induced the same patterns of early antigen diffuse components as the parental P3HR-1 virus
did. However, only P3HR-1 virus could induce EBV DNA synthesis in superinfected Raji cells, as determined
both by buoyant density centrifugation and by in situ cytohybridization with biotinylated recombinant EBV
DNA probes. Defective heterogeneous molecules present in P3HR-1 virus have been implicated in early antigen
induction after superinfection of Raji cells. Therefore, Southern blots of clone 13, P3HR-1, and B95-8 viruses
were hybridized to recombinant EBV fragments representing the sequences contained within the defective
molecules in P3HR-1. The parental P3HR-1 contained the previously described defective molecules. No
evidence for defective molecules was found in clone 13 or B95-8 viruses. These data indicate that concentrated
preparations of both clone 13 and B95-8 viruses can induce abortive infection in Raji cells, but while the
defective molecules are not needed for induction of early antigen diffuse components, they may be required for
the induction of viral DNA synthesis.
The virus-producing cell line P3HR-1, derived from the
Jijoye Burkitt lymphoma line, is a mixture of cells that
carries distinct variants of Epstein-Barr virus (EBV) (6, 8,
10). The heterogeneity of P3HR-1 virus has been demon-
strated by EBV nuclear antigen immunofluorescent staining
patterns (8), by partial denaturation mapping of viral DNA
(6), and by restriction endonuclease analysis (9, 27). Virus
released from this cell line fails to immortalize normal B
lymphocytes but can superinfect Raji cells, which already
contain latent EBV genomes, to induce early antigen (EA)
synthesis and produce virions that are able to immortalize
lymphocytes (7, 28).
Recently, there have been attempts to identify the
genomic alterations of the P3HR-1 strain responsible for the
ability to induce EA synthesis in Raji cells by subcloning the
heterogeneous cell population of the P3HR-1 line (10). About
200 distinct subclones of P3HR-1 were obtained. Like the
parental P3HR-1 virus, all the subclonal viruses lacked
immortalizing ability but retained cytotoxicity and the ability
to interfere with transformation by the B95-8 strain of EBV
(10). Furthermore, all the subclonal viruses lacked EA-
inducing capacity in superinfected Raji cells except for clone
5 (HH543-5) (25). Genomic structural analysis indicated that
both parental virus and virus derived from clone 5 contained
heterogeneous defective DNA fragments in contrast to the
viruses derived from the other subclones that lacked these
heterogeneous fragments. Thus, it was postulated that the
heterogeneous defective molecules are responsible for EA
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induction (10, 20, 25). As part of our attempts to understand
the molecular mechanism underlying the induction of ex-
pression of latent viral genomes, we have analyzed the
biologic properties and genomic structure of one of the
subclonal viruses (clone 13) thought to lack EA-inducing
capacity (10) compared with those of parental P3HR-1 and
B95-8 viruses.
We report here that both clone 13 and B95-8 viruses that
lack defective heterogeneous molecules can cause abortive
infection in Raji cells and induce EA synthesis. However,
defective heterogeneous molecules may be required for the
induction of viral DNA synthesis in superinfected Raji cells.
MATERIALS AND METHODS
Cell cultures and preparation of virus stocks. The lympho-
blastoid cell lines used in these studies were Raji, B95-8,
P3HR-1, and a subclone of P3HR-1, clone 13 (10). These
lines were propagated as suspension cultures at a cell density
of 5 x 105/ml in RPMI 1640 medium supplemented with 10%
fetal calf serum, streptomycin (100 ,ug/ml), and penicillin
(100 IU/ml), as described elsewhere (15). Clone 13 cells were
obtained from G. Miller.
Viral stocks were prepared from cultures of P3HR-1,
clone 13, and B95-8 which had been treated with 12-0-
tetradecanoyl-phorbol-12-acetate (TPA) at a concentration
of 30 ng/ml. The virus was pelleted from the cell-free
supernatant at 9,000 rpm for 90 min in a GS3 rotor (Ivan
Sorvall, Inc.). The centrifuge bottles were swabbed to re-
move residual medium and the virus pellets were suspended
in RPMI 1640 medium. The viral stocks were clarified to
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DAYS AFTER TPA INDUCTION
FIG. 1. Differential response to TPA induction of parental
P3HR-1 and clone 13 cells. (A) Parental P3HR-1 cells; (B) clone 13.
remove cellular debris by filtering through 1.2-, 0.8-, and
0.45-,um-pore-size filters and stored at 4°C. The P3HR-1 and
clone 13 virus stocks were prepared 14 days after the
addition of TPA and were concentrated 250-fold. The virus
from the B95-8 line was prepared 5 days after the addition of
TPA and was concentrated 350-fold.
DNA was prepared from a sample of each viral stock,
digested with EcoRI or BamHI endonuclease, and subjected
to electrophoresis through a 0.6% agarose gel (24). The
amount of virus-specific DNA in each preparation was
determined by ethidium bromide staining of the gel and
comparison to DNA standards. The concentration of viral
DNA indicated that the P3HR-1 and clone 13 viral stocks
contained 1.5 x 1010 viral genomes per ml, indicating that the
unconcentrated cell culture medium contained 6 x 107 viral
particles per ml. The B95-8 viral stocks contained 3 x 1010
viral genomes per ml or 9 x 107 virions per ml of culture
supernatant.
Determination of EBV genome copies per cell. Intracellular
viral genome copies were determined by cRNA-DNA hy-
bridization with an EBV-specific cRNA probe synthesized in
vitro, as described elsewhere (17).
Superinfection of Raji cells. Raji cells in the exponential
growth phase were pelleted and suspended in an appropriate
amount of the concentrated viral stock at cell concentrations
of 3.5 x 106 to 6 x 106 per ml and a viral multiplicity of
infection of 5,000 for the B95-8 virus and 2,500 for the
P3HR-1 and clone 13 viruses. After 1 h at 37°C in a CO2
incubator, the cells were pelleted, washed twice with phos-
phate-free minimal essential medium, and suspended in 1 ml
of the same buffer containing 2% dialyzed fetal calf serum.
To monitor the induction of viral DNA synthesis, at 6 h
postinfection, 200 ,uCi of 32p was added, and incubation
continued until 24 h after infection. Both superinfected and
mock-infected Raji cells were harvested, and DNA was
isolated and processed for analysis in cesium chloride den-
sity gradients, as described previously (16).
The synthesis of new viral proteins in superinfected Raji
cells was determined by incorporation of [35S]methionine.
The [35S]methionine-labeled proteins were analyzed on slab
gels in the Laemmli system (11). The electrophoretically
separated proteins in the gels were detected by fluorography
(1).
Analysis of polypeptides by Western blot. The induction of
viral protein synthesis was also analyzed by Western im-
munoblot. After electrophoresis, the transfer of proteins
from gels to nitrocellulose sheets (BA85; Schleicher &
Schuell, Inc.) was performed according to the diffusion
method (2) with slight modifications detailed previously (13,
14). Two identical sheets with mirror images of polypeptide
patterns were obtained after transfer by the diffusion
method. One sheet was reacted with human serum contain-
ing EA-viral capsid antigen-EBV nuclear antigen antibodies;
the other sheet was reacted with a monoclonal anti-EA
diffuse component (EA-D) antibody (22). The detailed pro-
cedures for detection of these antigens were reported re-
cently (13, 14).
Detection of EBV DNA replication by in situ cytohybridiza-
tion. Cloned BamHI-V DNA, which contains the large
internal repeated sequence within the EBV genome, was
labeled with biotin (Enzo Biochem) by nick translation,
according to the protocol of the manufacturer and as de-
scribed elsewhere (12).
Cell smears on slides were fixed with cold methanol-acetic
acid (3:1) for 15 min. Denaturation of DNA was carried out
by dipping slides in 0.07 N NaOH for 2 min, washing in
phosphate-buffered saline solution (PBS) for 5 min, and
dehydrating through 70 to 95% alcohol. The slides were
incubated at 80°C for 5 min in a moist chamber. The
biotinylated probe was denatured by heating in a boiling-
water bath for 5 min and quickly cooled on ice. The
denatured probe (400 ng) was added to a mixture of 50%
formamide, 10% dextran sulfate, 2x SSC (lx SSC is 0.15 M
NaCl plus 0.015 M sodium citrate), and 40 ,ug of heat-
denatured carrier salmon sperm DNA. The mixture was
applied onto the slides, which were then covered with
siliconized cover slips and sealed with rubber cement.
Hybridization was carried out at 80°C for 5 min, followed by
incubation at 37°C overnight. The cover slips were removed
gently, and slides were washed twice in 2x SSC for 5 min at
32°C and then in 0.1% Triton X-100 in PBS twice (5 min
each) at room temperature. Detection of hybridized biotinyl-
ated DNA was achieved by incubation for 1 h at 37°C with
fluorescein isothiocyanate-labeled avidin (Vector Laborato-
ries) diluted in PBS containing bovine serum albumin (2
mg/ml). After incubation, the slides were washed three times
in PBS. To reduce the background fluorescence, the slides
were immersed in 0.005% Evans blue in PBS for 1 min and
washed for 10 min in PBS.
Southern blot analysis. EBV DNAs were isolated and
purified from supernatant fluids of P3HR-1, clone 13, and
B95-8 cultures (15). Southern blots (26) were prepared with
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FIG. 2. Analysis of DNA synthesized in superinfected Raji cells
by equilibrium density centrifugation. (A) Raji cells superinfected by
P3HR-1 virus; (B) mock-infected Raji cells; (C and D) Raji cells
superinfected by clone 13 and B95-8 viruses, respectively. V, Viral
DNA; C, cellular DNA. Symbols: 0, Counts per minute; 0, density.
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FIG. 3. Detection of EBV DNA synthesis by in situ cytohybridization. The probe used was cloned BamHI-V DNA, which contains the
large internal repeated sequence within the EBV genome. The probe was labeled with biotin by nick translation. The technique clearly
distinguishes those cells that are synthesizing viral DNA at levels above the endogenous episomal content. (A) Raji cells superinfected by
P3HR-1 virus; (B) Raji cells superinfected by clone 13 virus; (C) mock-infected Raji cells; (D) Raji cells superinfected by B95-8 virus.
labeled recombinant DNA probes representing sequences
contained in the parental P3HR-1-defective molecules (4, 9).
RESULTS
Determination of EBV genome copies before and after
induction. To prepare virus for subsequent biologic and
molecular studies, as a first step, we compared the level of
responsiveness of parental P3HR-1 and clone 13 cells to TPA
induction. P3HR-1 and clone 13 cells contained 320 and 480
EBV genome copies per cell on the average, respectively
(Fig. 1). After TPA induction the viral genomes increased
fivefold (up to 1,600 copies per cell) in P3HR-1 and sevenfold
(up to 3,360 copies per cell) in clone 13. These preparations
and the B95-8 virus described subsequently were used for
the biologic experiments. The B95-8 virus also obtained by
induction with TPA was compared by Southern blot hybrid-
ization with the P3HR-1 and clone 13 viruses and found to be
about twofold more concentrated than P3HR-1 and clone 13.
Analysis of viral DNA synthesized in superinfected Raji
cells. To compare the biologic properties of the viruses, we
next analyzed the DNA synthesized in Raji cells after
superinfection. Superinfection of Raji cells with P3HR-1
virus resulted in shutdown of cellular DNA synthesis and
stimulation of synthesis of a large quantity of viral DNA
(Fig. 2A) as compared with the mock-infected Raji cells (Fig.
2B). In contrast, in Raji cells superinfected with virus from
clone 13 (Fig. 2C) and B95-8 (Fig. 2D), no detectable viral
DNA synthesis was induced, although cellular DNA synthe-
sis was slightly inhibited in both cases.
Detection of viral DNA synthesis by in situ cytohybridiza-
tion. To confirm the lack of capacity of clone 13 and B95-8
viruses to induce viral DNA replication, we performed an
alternate assay. In situ cytohybridization distinguishes those
cells that are synthesizing viral DNA at levels above the
endogenous episomal content. EBV DNA synthesis was
detected in approximately 90% of the Raji cells super-
infected with P3HR-1 virus (Fig. 3A), as judged by the
granular fluorescent staining within the nucleus. Although
similar cytopathic effects (formation of giant cells) were
observed in Raji cells superinfected with clone 13 (Fig. 3B)
and B95-8 (Fig. 3D), no granular fluorescent staining was
observed in these cells or in mock-infected cells (Fig. 3C).
Synthesis of EBV-induced polypeptides. Superinfection of
Raji cells with P3HR-1 virus produces a characteristic profile
ofEBV proteins (18). Synthesis ofEBV polypeptides in Raji
cells superinfected with virus derived from P3HR-1, clone
13, and B95-8 was analyzed by fluorography of radiolabeled
VOL. 61, 1987
1988 LIN AND RAAB-TRAUB





FIG. 4. Synthesis of EBV-induced polypeptides labeled by
[35S]methionine. Lanes: A, mock-infected Raji cells; B to D, Raji
cells superinfected by virus from P3HR-1, clone 13, and B95-8,
respectively. M.W., Molecular weight.
protein. Figure 4 shows the results of a fluorogram made by
exposing an electropherogram of "5S-labeled polypeptides
synthesized in superinfected Raji cells. Superinfection of
Raji cells with P3HR-1 virus (Fig. 4, lane B), as compared
with mock-infected cells (Fig. 4, lane A), resulted in the
synthesis of at least eight new polypeptides with molecular
weights of 145,000, 140,000, 135,000, 110,000, 92,000,
85,000, 52,000, and 32,000. In Raji cells infected with clone
13 and B95-8, the pattern was generally similar. However,
interestingly, the 140,000-molecular-weight polypeptide
(140K polypeptide) was undetectable in cells superinfected
with clone 13 virus (Fig. 4, lane C) and B95-8 virus (Fig. 4,
lane D). In addition, synthesis of the 145K, 135K, 110K, and
32K polypeptides was markedly reduced in clone 13 virus
(Fig. 4, lane C)- and B95-8 virus (Fig. 4, lane D)-infected
cells. The polypeptides synthesized in reduced amounts are
probably late polypeptides linked to viral DNA synthesis
(18).
The capacity of clone 13 and B95-8 viruses to induce EBV
polypeptides in superinfected Raji cells was further con-
firmed by the Western blotting-enzyme-linked immunosor-
bent assay technique. With human EA-positive viral capsid
antigen-positive serum, approximately 20 polypeptides with
molecular weights ranging from 32,000 to 220,000 can be
detected in Raji cells superinfected not only with P3HR-1
virus (Fig. 5, panel I, lane B) but also with clone 13 virus
(lane C) and B95-8 virus (lane D). However, again the 145K,
140K, 135K, and 110K polypeptides were either lacking or
markedly reduced in clone 13 virus-infected cells. Interest-
ingly, the 145K and 85K polypeptides were markedly in-
creased in B95-8 virus-infected cells (lane D). A distinct
band of EBV nuclear antigen-1 (68,000) was detected in both
infected and mock-infected Raji cells (lane A).
To cross-identify EA-Ds with those of EBV-induced
polypeptides, the second nitrocellulose sheet (Fig. 5, panel
II), which is the mirror image of the first sheet, was reacted
with a monoclonal antibody against EA-Ds. Identical protein
banding patterns that represent EA-Ds between the molec-
ular weights of 46,000 and 55,000 were observed in cells
superinfected with virus from clone 13 (lane C), P3HR-1
(lane B), and B95-8 (lane D). EA-Ds were readily detectable
in B95-8 virus-infected cells (lane D) and were also clearly
detected, but at lower levels, in clone 13 virus-infected cells
(lane C). No EA-D polypeptides were detected in mock-
infected Raji cells (lane A).
Detection of defective heterogeneous molecules by Southern
blot analysis. The exceptional ability of the P3HR-1 strain of
EBV to activate latent genomes has been linked to the
presence of submolar heterogeneous DNA molecules (10)
which contain sequences from separated regions of the EBV
genome in an unusual linkage. The rearrangement of se-
quences generates new fragments after restriction enzyme
digestion. The sequences represented in the heterogeneous
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FIG. 5. Western blot analysis of EBV-induced polypeptides. (I)
Western blot reacted with human EA-positive viral capsid antigen-
positive serum; (II) mirror image of the Western blot of panel I
reacted with monoclonal antibody against EA-D. Lanes: A, mock-
infected Raji cells; B to D, Raji cells superinfected by virus from
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FIG. 6. EBV DNA sequences which are represented in P3HR-1 heterogeneous molecules. Four regions (a, 1B, y, and 8) of the EBV
genome have been identified in heterogeneous molecules in the P3HR-1 strain of EBV. These regions are joined in an unusual linkage which
results in restriction enzyme fragments containing sequences from regions which are widely separated on the EBV genome (4, 7). TR,
Terminal repeat; IR, internal repeat; d, daltons.
molecules and the sequence alignment have been analyzed
by infection of the EBV-negative BJAB cell line with
P3HR-1 virus (4). In these cells, the defective molecules are
preferentially synthesized. They contain sequences from
four separate regions of the regular viral genome designated
a, ,3, -y, and 8 (Fig. 6). However, the particular sequences
contained in the rearranged molecules vary somewhat, and
the novel fragments differ in molecular weight and sequence
content in several different studies. To determine whether
the high levels of viral production induced by TPA had
resulted in the spontaneous generation of defective, hetero-
geneous DNA molecules in B95-8 or clone 13, DNA from
each virus preparation used for superinfection studies was
analyzed. Southern blots were prepared with EcoRI- or
BamHI-digested DNA and hybridized to 32P-labeled recom-
binant DNA probes representing sequences contained in the
P3HR-1-defective molecules. Hybridization with BamHI-V,
-X, -Y, or -BR readily identified multiple heterogeneous
EcoRI fragments in the P3HR-1 strain but not in B95-8 or
clone 13 (Fig. 7A). The 6.6-kilobase pair (kbp) fragment
identified with BamHI-V was also identified with the
BamHI-C probe. Hybridization with BamHI-Bl to EcoRI
digestions identified the smaller EcoRI-C in B95-8 resulting
from a 12-kbp deletion in this fragment.
Previous studies have shown that a 2.4-kbp BamHI frag-
ment homologous to BamHI-Y is capable of activating
latently infected EBV cell lines into virus production (5).
This fragment is detected at low levels in the P3HR-1 strain
but not in clone 13 or B95-8 (Fig. 7B). BamHI-M and -B1
identify a 9.6-kbp BamHI fragment in P3HR-1 which is not
detected in clone 13 or B95-8.
DISCUSSION
The B95-8 and P3HR-1 strains of EBV differ greatly in
their biologic properties. The P3HR-1 strain cannot trans-
form lymphocytes in vitro, whereas B95-8 readily transforms
lymphocytes after infection (21). The inability of the P3HR-1
strain to transform lymphocytes correlates with a deletion in
the U2 region of its genome, which encodes EBV nuclear
antigen-2. However, P3HR-1 can efficiently induce the syn-
thesis of early replicative antigens in the latently infected
Raji cell line and in some cases induces virus replication.
The ability of the P3HR-1 strain to activate EA synthesis and
viral DNA replication in latently infected cell lines has been
linked to the heterogeneous defective DNA molecules pre-
sent only in the P3HR-1 strain (10). Our observation that
B95-8 can also induce EA synthesis contradicts previous
observations (21) about the biologic properties of this virus
and raised a concern that our B95-8 virus was contaminated
with another EBV strain. However, B95-8 has a well-
characterized 12-kbp deletion in the EcoRI C fragment (24).
Hybridization with BamHI-B1 to EcoRI digestions identified
the smaller EcoRI-C in B95-8 (Fig. 7A) and showed slight
hybridization to the EcoRI A fragment resulting from dupli-
cated sequences in BamHI-B1 and -H. Hybridization of
BamHI-B1 to BamHI-digested DNA identified the Bi frag-
ment both in P3HR-1 and in clone 13, a 9.6-kbp defective
fragment in P3HR-1, and BamHI H and I fragments in B95-8.
These results, in accord with previous studies on the DNA
structure of P3HR-1 and B95-8 (9, 24), prove the identity of
each of the strains used in these experiments and indicate
that defective molecules have not been generated in clone 13
and B95-8 viruses.
Our data reveal that, like the parental P3HR-1 virus, both
clone 13 and B95-8 viruses that lack defective molecules can
cause abortive infections resulting in induction of EA syn-
thesis in superinfected Raji cells. Although these results
suggest that defective molecules are not required for EA
induction, Southern blot analysis of the DNA content of the
virus preparations used for these studies indicated that they
were highly concentrated. Comparison of the intracellular
EBV genome copies and the amount of viral DNA in the
culture fluids indicate that the TPA-induced P3HR-1, clone
13, and B95-8 cell cultures produced amounts of virus similar
to those produced in previous studies. However, the viral
stocks used in the experiments described here were concen-
trated 250- to 350-fold, whereas previous studies had used
unconcentrated cell supernatant fluid from the P3HR-1 cell
line or pelleted virus from the TPA-induced non-EA-
inducing cell clones concentrated 35-fold. Therefore, the
multiplicity of the Raji superinfection in these experiments
was 10- to 100-fold higher than that used in previous studies
(10, 20, 21, 25).
A relation between EA induction and multiplicity of
infection suggests that the activating function may be a
virion component. A virion component of herpes simplex
virus has been identified which trans-activates the expres-
sion of the alpha functions of herpes simplex virus (3, 23).
Our data suggest that perhaps EBV also contains a virion
component that induces the synthesis of early functions after
superinfection of latently infected cells. However, parental
P3HR-1 containing defective molecules not only efficiently
induces the synthesis of early functions but also induces
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FIG. 7. Detection of defective heterogeneous DNA molecules by Southern blot analysis. DNA was extracted from each virus preparation
used for superinfection studies, digested with EcoRI or BamHI, and hybridized to recombinant DNA probes representing sequences which
are contained in the P3HR-1-defective molecules. The nondefective fragments are identified by letters, and additional fragments are indicated
by size (in kilobase pairs).
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viral DNA synthesis. Our observations confirm the previous
studies (4, 19) which indicated that defective DNA was
required for activation of viral DNA synthesis.
It is unknown why the defective molecules are apparently
needed for induction of viral DNA replication, whereas the
intact viral genomes in clone 13 and B95-8 do not themselves
induce viral DNA synthesis. One possibility is that the viral
DNA synthesis detected after superinfection is largely due to
preferential replication of the defective molecules. Other
studies have indicated that the defective genomes are pref-
erentially replicated after superinfection (19). In addition, a
particular restriction enzyme fragment from defective
genomes can permanently transform a nonpermissive cell
line into a productively infected cell line (5). Perhaps the
defective molecules encode an altered or perhaps
misregulated viral function which activates lytic origins of
replication. Such sequences may be overrepresented in the
defective genomes.
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